← Back to headlines
Corcept Therapeutics (CORT) Gains on FDA Approval Amid Lingering Questions
Corcept Therapeutics Incorporated (CORT) has seen gains following FDA approval for its product, though some questions regarding the company's future prospects reportedly remain.
1 Apr, 09:34 — 1 Apr, 09:34
Sources
Showing 1 of 1 sources
